Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zentase (EUR-1008) in chronic pancreatitis with exocrine pancreatic insufficiency
2008-000061-37Phase 3Completed
- Sponsor
- Eurand
- Start
- May 2008
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pancrelipase in chronic pancreatitis (CP), exocrine pancreatic insufficiency (EPI) and gastrointestinal conditions (2 arms), sponsored by Eurand. Primary endpoint: Coefficient of Fat Absorption improvement with high-dose Zentase vs placebo. Started May 2008; status: completed.
02
Drugs
pancrelipase
03
Conditions
chronic pancreatitis (CP)exocrine pancreatic insufficiency (EPI)gastrointestinal conditions
Beyond the preview
Go deeper on 2008-000061-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000061-37.